SCHEMBL806438

SCHEMBL806438

COc1ccc(S(=O)(=O)N(CC(=O)Nc2ccccc2-c2ccccc2)c2ccc(C)cc2)cc1

nearest known ligand 0.83

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.83
HPGD P15428 1/20 0.68
ATM Q13315 1/20 0.68
L3MBTL1 Q9Y468 1/20 0.68
LMNA P02545 2/20 0.67
GAA P10253 1/20 0.67
OXTR P30559 3/20 0.66
AVPR1A P37288 2/20 0.66
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
MAPT P10636 3/20 0.63
ALDH1A1 P00352 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806760 0.96 SMN1; SMN2 (0.75) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL798403 0.91 OXTR (0.69) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL17340105 0.91 SMN1; SMN2 (0.68) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL806780 0.91 SMN1; SMN2 (1.00) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL10053396 0.88 SMN1; SMN2 (0.86) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL798762 0.85 MAPT (0.67) SMN1; SMN2HPGDATML3MBTL1LMNA
SCHEMBL17340103 0.85 TP53 (0.74) SMN1; SMN2LMNAOXTRAVPR1AMEN1
SCHEMBL806651 0.84 OXTR (0.66) SMN1; SMN2OXTRAVPR1AMEN1KMT2A
SCHEMBL3366701 0.82 OXTR (0.82) SMN1; SMN2LMNAOXTRAVPR1AMEN1
SCHEMBL18963016 0.81 MAPT (0.79) SMN1; SMN2OXTRAVPR1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9212134-B2 Inhibitors of viral entry into mammalian cells MICROBIOTIX, INC. (US) 2015-12-15 US disclosed
WO-2012037119-A2 INHIBITORS OF VIRAL ENTRY INTO MAMMALIAN CELLS MICROBIOTIX, INC. (US) 2012-03-22 WO disclosed